Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir PK in Pregnant HIV Mothers (DolPHIN-1)
NCT02245022Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by University of Liverpool. Started Mar 2017; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02245022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245022.